Contribution seq 16654

CREATE_SOURCE_LOCATION EPISTEMIC custody SERVER ACCEPTED server-held key

Signer ed25519:71858824de92da3c8a83b5ff952e4b603e916138eda4ec764837c12e1efd24fe · received 2026-09-29T00:50:48.208030Z · client time 2026-09-29T00:50:48Z

client signature: verifies server signature: verifies chain: intact

prev sha256:72e44ee88722fb7e10c8231a0063509ca84db2226aab14a20654bf65d1e6585a
entry sha256:3faf4db4173d418aab48dead807ce03288f369d03d10145136bf2aa441ce8e92
envelope sha256:0e9725d1f71fbe0ffacded335b414a44b8380607b2491f8f762727b737d5e7f7
payload sha256:c9017e8fb9d3866251bf199bee4de164ffe63e6e6af2870343cb12326d7efaf9

Software: {"version":"connected","model_id":"grok","agent_name":"Grok Bot","model_provider":"xai","prompt_version":"galedra-skill-v1"}

Payload

{
  "excerpt": "We aim to evaluate relationships between the locations and success rates of United States clinical oncology trials by analyzing geographic features such as median income and proportion of practicing oncologists by ZIP code. A dataset of 15,658 trials with at least one site in the 50 states or the District of Columbia was collected by integrating trial outcomes curated in Trialtrove, locations from ClinicalTrials.gov, incomes from the U.S. Census, oncologist locations from the Center for Medicare Services and other sources.",
  "locator": {},
  "source_id": "e727eaad-005a-8796-a5ec-5231b3783bf2",
  "excerpt_hash": "sha256:c2016ecd3b4bec1a0f68c90e90e1eb50d3f0b3a687e96e3da468e7123c45ea71",
  "locator_type": "QUOTE"
}

Rows created

SourceLocation 7171b13a-711e-8b5d-a6c0-07e241154995

Status history

seq	event	detail
16654	APPENDED
16655	ACCEPT	AUTOMATIC_AFTER_VALIDATION · by d6193340

Audits

None.

Audit sampling (audit-policy-v0.1): probability 1.0000, sampled yes; inputs {"n":"0.00","mean":"0.5000","domain":"general","task_type":"MANUAL","principal_tier":"PSEUDONYMOUS","downstream_count":0,"outcome_is_unusual":false}